The current study aimed to investigate the role of Ki-67 as a prognostic marker, to identify any correlations between Ki-67 expression and other clinical and histopathological parameters, and to determine the optimal cut-off value of Ki-67 in a large cohort of females with BC. The gene discussed is MKI67; the disease is breast cancer.